drug

CX-801

1 story · latest Aug 6, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by CytomX Therapeutics

Timeline

CytomX reports Q2 2026 results, advances Varseta-M toward first registrational study

Aug 6Quarterly updateCytomX Therapeutics

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.